Mesenchymal Stem Cells Loaded in Injectable Alginate Hydrogels Promote Liver Growth and Attenuate Liver Fibrosis in Cirrhotic Rats
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Cirrhosis, a marker of severe liver diseases, limits future liver remnant (FLR) growth, preventing many cancer patients from undergoing surgery. While portal vein blockade (PVB) techniques are used to stimulate liver regeneration, 20–30% of patients still fail to achieve the required growth. Although mesenchymal stem cell (MSC) therapy improves PVB, its efficacy is limited by poor cell retention. To address this, we utilized alginate hydrogels to deliver MSCs and improve their retention. MSCs were loaded in the hydrogel and injected intraportally in cirrhotic rats. Liver volume, weights, enzyme levels, and histology were monitored. Results showed that the hydrogel maintained 89.0 ± 3.0% cell viability and gradually released MSCs for over two weeks. Furthermore, the rats injected with the MSC-loaded hydrogel demonstrated higher liver volumes (FLR ratio of 0.57 ± 0.32) and weights (FLR ratio of 0.84 ± 0.05). The treated rats exhibited more improved liver enzymes (AST: 72.75 ± 14.17 U/L, ALP: 135.67 ± 41.20 U/L, ALT: 46.00 ± 2.94 U/L) and decreased fibrotic areas in the liver (4.52 ± 0.22%) compared to the control group. Histology revealed increased retention when MSCs were delivered with the hydrogel (37.30 ± 16.10 MSCs/mm2) compared to cells alone (21.70 ± 22.10 MSCs/mm2). Overall, the MSC-loaded hydrogels enhanced the growth and reduced the fibrosis of the liver by promoting cell retention and efficacy in cirrhotic rats. This approach holds significant potential for improving outcomes among cancer patients, offering a promising therapeutic strategy for liver regeneration and treatment of liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Various biomaterials, such as alginate hydrogels, have been used to load MSCs, which can greatly improve the efficacy of MSC-based therapy [367].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [367]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alginate: Properties and biomedical applications
Lee, K. Y., & Mooney, D. J. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.06.003 · Cited by 8,095 · cited 1×
“Alginate is a natural polymer that does not degrade to toxic byproducts [19,20], as compared with some synthetic polymers [21,22].”
Sepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., Poustchi, H., Tsoi, D., Colombara, D. V., Abdoli, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30349-8 · Cited by 1,714 · cited 1×
“Cirrhosis is a hallmark of all chronic liver diseases, affecting 122 million people and causing about two million deaths globally [1,2].”
Global epidemiology of cirrhosis — aetiology, trends and predictions
Huang, D. Q., Terrault, N. A., Tacke, F., Gluud, L. L., Arrese, M., Bugianesi, E., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00759-2 · Cited by 839 · cited 1×
“Cirrhosis is a hallmark of all chronic liver diseases, affecting 122 million people and causing about two million deaths globally [1,2].”
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667 · cited 1×
“MSCs lose their efficacy due to prolonged exposure to a suboptimal microenvironment and the loss of supporting extracellular matrix (ECM) [16,17].”
Alginates as a useful natural polymer for microencapsulation and therapeutic applications
Goh, C. H., Heng, P. W. S., & Chan, L. W. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.11.012 · Cited by 655 · cited 1×
“Alginate is a natural polymer that does not degrade to toxic byproducts [19,20], as compared with some synthetic polymers [21,22].”
Abasalizadeh, F., Moghaddam, S. V., Alizadeh, E., akbari, E., Kashani, E., Fazljou, S. M. B., Torbati, M., & Akbarzadeh, A. (2020) · Journal of Biological Engineering · doi:10.1186/s13036-020-0227-7 · Cited by 608 · cited 1×
“They can form injectable hydrogels, comprising a three-dimensional network of polymers that contain a large amount of water [23].”
The carbon tetrachloride model in mice
Scholten, D., Trebicka, J., Liedtke, C., & Weiskirchen, R. (2015) · Laboratory Animals · doi:10.1177/0023677215571192 · Cited by 414
Tag, C. G., Sauer-Lehnen, S., Weiskirchen, S., Borkham-Kamphorst, E., Tolba, R. H., Tacke, F., & Weiskirchen, R. (2015) · Journal of Visualized Experiments · doi:10.3791/52438 · Cited by 306
Li, P., Ou, Q., Shi, S., & Shao, C. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00998-y · Cited by 250 · cited 1×
“The therapeutic potential of MSCs is largely attributed to their ability to differentiate into hepatocyte-like cells [12] and their capability to produce regenerative growth factors and immunomodulatory cytokines [13,14].”
Animal models of chronic liver diseases
Liu, Y., Meyer, C., Xu, C., Weng, H., Hellerbrand, C., ten Dijke, P., & Dooley, S. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2012 · Cited by 226
Tarao, K., Nozaki, A., Ikeda, T., Sato, A., Komatsu, H., Komatsu, T., Taguri, M., & Tanaka, K. (2019) · Cancer Medicine · doi:10.1002/cam4.1998 · Cited by 205 · cited 1×
“It is the most potent risk factor for liver malignancies (i.e., 80% to 90% of patients with hepatocellular carcinoma have cirrhosis) [3].”
Hwang, S., Lee, S.-G., Ko, G.-Y., Kim, B.-S., Sung, K.-B., Kim, M.-H., Lee, S.-K., & Hong, H.-N. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31819ecc5c · Cited by 193
Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis
Dong, S., Chen, Q.-L., Song, Y.-N., Sun, Y., Wei, B., Li, X.-Y., Hu, Y.-Y., Liu, P., & Su, S.-B. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.561 · Cited by 191
Clinical and Diagnostic Significance of Lactate Dehydrogenase and Its Isoenzymes in Animals
Klein, R., Nagy, O., Tóthová, C., & Chovanová, F. (2020) · Veterinary Medicine International · doi:10.1155/2020/5346483 · Cited by 188
Animal models of drug-induced liver injury
McGill, M. R., & Jaeschke, H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.037 · Cited by 185
Dai, C., Xiao, X., Li, D., Tun, S., Wang, Y., Velkov, T., & Tang, S. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1136-2 · Cited by 182
Zhang, X., Yin, Z., Xiang, S., Yan, H., & Tian, H. (2024) · Polymers · doi:10.3390/polym16192807 · Cited by 181 · cited 1×
“Alginate is a natural polymer that does not degrade to toxic byproducts [19,20], as compared with some synthetic polymers [21,22].”
Automated Hepatic Volumetry for Living Related Liver Transplantation At Multisection CT
Nakayama, Y., Li, Q., Katsuragawa, S., Ikeda, R., Hiai, Y., Awai, K., Kusunoki, S., Yamashita, Y., Okajima, H., Inomata, Y., et al. (2006) · Radiology · doi:10.1148/radiol.2403050850 · Cited by 177
Programmable microencapsulation for enhanced mesenchymal stem cell persistence and immunomodulation
Mao, A. S., Özkale, B., Shah, N. J., Vining, K. H., Descombes, T., Zhang, L., Tringides, C. M., Wong, S.-W., Shin, J.-W., Scadden, D. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819415116 · Cited by 177 · cited 1×
“They protect MSCs from the hostile environment of the diseased liver, reducing immune-mediated clearance and prolonging cell survival [30].”
Biomaterials to enhance stem cell transplantation
Kharbikar, B. N., Mohindra, P., & Desai, T. A. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.002 · Cited by 172 · cited 1×
“Recent studies have shown that hydrogel biomaterials possess bioactive properties beneficial for MSC growth and function [24–26].”
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153 · cited 2×
“Furthermore, alginate hydrogels sustain the release of paracrine factors that promote tissue repair and reduce fibrosis in the liver [31].”
New frontiers in liver resection for hepatocellular carcinoma
Allaire, M., Goumard, C., Lim, C., Cleach, A. L., Wagner, M., & Scatton, O. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100134 · Cited by 142
Boyd, J. (1962) · Research in Veterinary Science · doi:10.1016/s0034-5288(18)34899-9 · Cited by 138
Quinlan, E., López-Noriega, A., Thompson, E. M., Hibbitts, A., Cryan, S. A., & O'Brien, F. J. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2013 · Cited by 122
Ansari, S., Chen, C., Xu, X., Annabi, N., Zadeh, H. H., Wu, B. M., Khademhosseini, A., Shi, S., & Moshaverinia, A. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1594-6 · Cited by 110 · cited 1×
“Alginate hydrogels are explored as MSC delivery systems to treat many diseases, including liver cirrhosis [27–29].”
O-GlcNAc transferase suppresses necroptosis and liver fibrosis
Zhang, B., Li, M.-D., Yin, R., Liu, Y., Yang, Y., Mitchell-Richards, K. A., Nam, J. H., Li, R., Wang, L., Iwakiri, Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127709 · Cited by 89
Alvarez, F. A., Castaing, D., Rodrigo Figueroa, J., Allard, M., Golse, N., Pittau, G., Ciacio, O., Cunha, A. S., Cherqui, D., Azoulay, D., et al. (2018) · Surgery · doi:10.1016/j.surg.2017.12.027 · Cited by 80
Fortea, J. I., Fernández-Mena, C., Puerto, M., Ripoll, C., Almagro, J., Bañares, J., Bellón, J. M., Bañares, R., & Vaquero, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27427-9 · Cited by 78
Biomaterials for liver tissue engineering
Jain, E., Damania, A., & Kumar, A. (2013) · Hepatology International · doi:10.1007/s12072-013-9503-7 · Cited by 73 · cited 1×
“MSCs can transdifferentiate to hepatocyte-like cells that aid in repopulating the liver [59].”
Pangjantuk, A., Kaokaen, P., Kunhorm, P., Chaicharoenaudomrung, N., & Noisa, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-54912-1 · Cited by 70 · cited 2×
“…( OCT-4 , NANOG , SOX2 , and SIRT1 ), tissue growth and development ( YAP and TAZ ), cell proliferation (Ki67), and telomere activity ( hTERT ) [33]. attributed the MSC survival to the increased expression of genes related to stemness ( OCT-4 , NANOG , SOX2 , and SIRT1 ), tissue growth and…”
Young, S. A., Sherman, S. E., Cooper, T. T., Brown, C. F. C., Anjum, F., Hess, D. A., Flynn, L. E., & Amsden, B. G. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.008 · Cited by 63
Babu, S., Albertino, F., Omidinia‐Anarkoli, A., & Laporte, L. D. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002221 · Cited by 60
Jeon, O., Lee, Y. B., Lee, S. J., Guliyeva, N., Lee, J., & Alsberg, E. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.025 · Cited by 58
Mishra, A., Pandey, V. K., Shankar, B. S., & Melo, J. S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111445 · Cited by 57 · cited 2×
“Al-ginate Alginate hydrogels may have acted as a supportive matrix for cells due to their inherent biocompatibility and nontoxicity [18]. hydrogels may have acted as a supportive matrix for cells due to their inherent biocompatibility and nontoxicity [18].”
Self-citationHuman mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice
Itaba, N., Matsumi, Y., Okinaka, K., Ashla, A. A., Kono, Y., Osaki, M., Morimoto, M., Sugiyama, N., Ohashi, K., Okano, T., et al. (2015) · Scientific Reports · doi:10.1038/srep16169 · Cited by 55 · cited 1×
“The therapeutic potential of MSCs is largely attributed to their ability to differentiate into hepatocyte-like cells [12] and their capability to produce regenerative growth factors and immunomodulatory cytokines [13,14].”
Hunt, N. C., Shelton, R. M., Henderson, D. J., & Grover, L. M. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0197 · Cited by 53
Khatab, S., Leijs, M. J. C., van Buul, G. M., Haeck, J. C., Kops, N., Nieboer, M. F., Bos, P. K., Verhaar, J. A. N., Bernsen, M. R., & van Osch, G. J. V. M. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09532-6 · Cited by 52
Seo, K., Sohn, S., Bhang, D., Nam, M., Lee, H., & Youn, H. (2014) · Cell Biology International · doi:10.1002/cbin.10186 · Cited by 50
Ghanta, R. K., Aghlara-Fotovat, S., Pugazenthi, A., Ryan, C. T., Singh, V., Mathison, M. N., Jarvis, M., Mukherjee, S., Hernández, A., & Veiseh, O. (2020) · Biomaterials Science · doi:10.1039/d0bm00855a · Cited by 49 · cited 1×
“Alginate hydrogels are explored as MSC delivery systems to treat many diseases, including liver cirrhosis [27–29].”
Actual 10-year survival following hepatectomy for hepatocellular carcinoma
Franssen, B., Jibara, G. A., Tabrizian, P., Schwartz, M., & Roayaie, S. (2013) · HPB · doi:10.1111/hpb.12206 · Cited by 47 · cited 1×
“The high degree of underlying cirrhosis prevents patients from undergoing liver resection Gels 2025 , 11 , 250 2 of 15 because it limits the regenerative capacity of the future liver remnant (FLR) [4].”
Wang, W., Du, Z., Yan, J., Ma, D., Shi, M., Zhang, M., Peng, C., & Li, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112532 · Cited by 43 · cited 2×
“Then, MSCs can exert more of their therapeutic effect, optimally resulting in higher liver mass regeneration and improvements in liver function markers [57,58].”
Wang, J.-L., Ding, H.-R., Pan, C.-Y., Shi, X.-L., & Ren, H.-Z. (2021) · Cell Death & Disease · doi:10.1038/s41419-020-03374-0 · Cited by 42 · cited 1×
“Current research explores the application of mesenchymal stem cells (MSCs) for ameliorating liver cirrhosis [10].”
Rodimova, S. A., Mozherov, A. M., Elagin, V. V., Karabut, M. M., Shchechkin, I. D., Kozlov, D., Krylov, D. P., Gavrina, A. I., Bobrov, N., Загайнов, В. Е., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119112 · Cited by 41 · cited 1×
“A considerable number of patients do not meet these thresholds and become unsuitable for curative resection because of higher risk for post-hepatectomy liver failure [5,6].”
Tuning the rheological properties of chitosan/alginate hydrogels for tissue engineering application
Enoch, K., S, R. C., & Somasundaram, A. A. (2024) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2024.134434 · Cited by 38 · cited 1×
“This allows for controlled intraportal delivery and enables MSCs to directly enter the liver [32].”
Ezquer, F., Bahamonde, J., Huang, Y.-L., & Ezquer, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0469-y · Cited by 35 · cited 2×
“Then, MSCs can exert more of their therapeutic effect, optimally resulting in higher liver mass regeneration and improvements in liver function markers [57,58].”
Farjadian, F., Akbarizadeh, A. R., & Tayebi, L. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04747 · Cited by 35
Remes, A. K., Basha, D. I., Puehler, T., Borowski, C., Hille, S. S., Kummer, L., Wagner, A. H., Hecker, M., Soethoff, J. P., Lutter, G., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.017 · Cited by 35
Lim, C., & Farges, O. (2012) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2012.03.003 · Cited by 33 · cited 1×
“In an attempt to induce FLR growth, preoperative portal vein blockade (PVB) (e.g., portal vein ligation (PVL) or portal vein embolization (PVE)) is performed before major liver resection [7].”
Reyes, M. S. S., & Medina, P. M. B. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124428 · Cited by 30 · cited 1×
“Alginate is a natural polymer that does not degrade to toxic byproducts [19,20], as compared with some synthetic polymers [21,22].”
Barcena, A. J. R., Mishra, A., Bolinas, D. K. M., Martin, B. M., & Melancon, M. P. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2906228 · Cited by 30
Self-citationMesenchymal stem cells to treat liver diseases
Eom, Y. W., Kang, S. H., Kim, M. Y., Lee, J. I., & Baik, S. K. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.163 · Cited by 29
In Vitro Biological Performance of Alginate Hydrogel Capsules for Stem Cell Delivery
de Souza, J. B., Rosa, G. D. S., Rossi, M. C., Stievani, F. D. C., al., J. P. H. P. E., Krieck, A. M. T., Bovolato, A. L. D. C., Fonseca‐Alves, C. E., Amigó, V., & Alves, A. L. G. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.674581 · Cited by 28 · cited 2×
“…findings of high cell viability for two weeks using a composite of gelatin–alginate hydrogel scaffold [34] as well as alginate microcapsules [35]. studies also reported similar findings of high cell viability for two weeks using a composite of gelatin– alginate hydrogel scaffold [34] as well…”
Joddar, B., Tasnim, N., Thakur, V., Kumar, A., McCallum, R. W., & Chattopadhyay, M. (2018) · Bioengineering · doi:10.3390/bioengineering5010012 · Cited by 23
Barcena, A. J. R., Perez, J. V. D., Bernardino, M. R., Damasco, J. A., Valentin, E. M. D. S., Klusman, C., Martin, B., Canlas, G. M., Heralde, F. M., Fowlkes, N. W., et al. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.214052 · Cited by 22 · cited 1×
“The therapeutic potential of MSCs is largely attributed to their ability to differentiate into hepatocyte-like cells [12] and their capability to produce regenerative growth factors and immunomodulatory cytokines [13,14].”
Self-citationHermansyah, D., Putra, A. B., Muhar, A. M., Retnaningsih, R., Wirastuti, K., & Dirja, B. T. (2021) · Medical Archives · doi:10.5455/medarh.2021.75.16-22 · Cited by 21
Elzainy, A., Sadik, A. E., & Altowayan, W. M. (2024) · Biomolecules · doi:10.3390/biom14030297 · Cited by 20
Hyaluronan-Based Grafting Strategies for Liver Stem Cell Therapy and Tracking Methods
Nevi, L., Safarikia, S., Matteo, S. D., Biancaniello, F., Chiappetta, M. F., & Cardinale, V. (2019) · Stem Cells International · doi:10.1155/2019/3620546 · Cited by 17 · cited 1×
“MSCs lose their efficacy due to prolonged exposure to a suboptimal microenvironment and the loss of supporting extracellular matrix (ECM) [16,17].”
Barcena, A. J. R., Owens, T. C., Melancon, S., Workeneh, I., Cao, H. S. T., Vauthey, J., & Huang, S. Y. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10719-1 · Cited by 17 · cited 1×
“Because of this, MSC therapy is explored as an augmentative strategy for PVB to achieve maximal volumetric gain in a short amount of time [15].”
Self-citationShi, X., Zhang, K., Qi, Q., Zhou, W., Yu, F., & Zhang, Y. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09664-6 · Cited by 13 · cited 2×
“Several mechanisms reported in the literature include immunomodulation by transforming growth factor-beta (TGF-β ) suppression, ECM remodeling, and pro-regenerative signaling [54–56].”
Rezaei, S., Shakibaie, M., Kabir‐Salmani, M., Moghaddam, M. S., Rezvani, M., Shahali, M., & Naseri, M. (2016) · Iranian Journal of Biotechnology · doi:10.15171/ijb.1185 · Cited by 12 · cited 2×
“Other Other studies also reported similar findings of high cell viability for two weeks using a composite of gelatin–alginate hydrogel scaffold [34] as well as alginate microcapsules [35]. studies also reported similar findings of high cell viability for two weeks using a composite of gelatin–…”
Kumar, S., Kabat, M., Basak, S., Babiarz, J. P., Berthiaume, F., & Grumet, M. (2022) · Biomolecules · doi:10.3390/biom12121803 · Cited by 11
Svitlana, R., Pikus, P. O., Buchek, P., Nadiia, S., Ianina, P., Dmytro, I., & Vitaly, K. (2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac124.50545070 · Cited by 7
Mishra, A., Melo, J. S., & Bhainsa, K. C. (2023) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/s43578-023-01056-z · Cited by 7
Self-citationSa’dyah, N. A. C., Putra, A. B., Dirja, B. T., Hidayah, N., Azzahara, S. Y., & Irawan, R. C. S. (2021) · Universa Medicina · doi:10.18051/univmed.2021.v40.29-35 · Cited by 6 · cited 2×
“Several mechanisms reported in the literature include immunomodulation by transforming growth factor-beta (TGF-β ) suppression, ECM remodeling, and pro-regenerative signaling [54–56].”
Joddar, B., Tasnim, N., Thakur, V., et al. (2018) · Preprints.org · doi:10.20944/preprints201801.0033.v1 · Cited by 4
[Experimental promotion of liver regeneration after portal vein branch ligation].
Liška, V., Treska, V., Mírka, H., Vyčítal, O., Brůha, J., Haidingerova, L., Beneš, J., Tonar, Z., Pálek, R., & Rosendorf, J. (2018) · Perspectives in Surgery · doi:10.33699/pis.2018.97.5.239-245 · Cited by 2
Cited by
Choi, S., & Jeong, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020619 · Cited by 12
“Preclinical models have demonstrated that hydrogel-based MSC delivery augments anti-inflammatory and antifibrotic effects in liver fibrosis [111,119].”
Magnetic Nanocomposite Hydrogels in Orthopedics: Applications and Perspectives
Shi, S., He, S., Lin, Q., & Sun, S. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s539423 · Cited by 10
Chandramouli, A., Babu, R., Gopal, K., Manjari, R. S., Kaliannagounder, V. K., Park, C. H., & Jayakumar, R. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150761 · Cited by 3
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2
Mesenchymal Stem Cells in Liver Fibrosis: A Dose-Dependent Recovery
Lyundup, A. V., Shagidulin, M. Y., Онищенко, Н. А., Beregovykh, V. V., Крашенинников, М. Е., Venediktov, A. A., Pokidova, K., Nikolskaya, A. O., Kuzmin, E. A., Kostin, A. A., et al. (2025) · Applied Sciences · doi:10.3390/app151910471 · Cited by 2
Metadata
- Authors
- Bolinas, D. K. M., Barcena, A. J. R., Mishra, A., Bernardino, M. R., Lin, V., Heralde, F. M., Chintalapani, G., Fowlkes, N. W., Huang, S. Y., & Melancon, M. P.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of the Philippines Manila (PH)
- Corresponding author
- Melancon, Marites P.
- ORCID
- Venue
- Gels
- Publisher
- MDPI AG
- Published
- 2025-03-27
- Volume
- 11
- Issue
- 4
- Pages
- 250
- ISSN
- 2310-2861 (ISSN-L)
- PMC
- PMC12027234
- OpenAlex
- W4408928598
- Cited by
- 20
- References
- 66
- Citations by year
- 2026: 16 · 2025: 4
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Gels (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health—National Cancer Institute (P30CA016672, R25 CA-265800-01A1)
- Joint Center for Computational Oncology (JCCO) Pilot Grant (P30CA016672, R25 CA-265800-01A1)
- Department of Science and Technology-Philippine Council for Health Research and Development (P30CA016672, R25 CA-265800-01A1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- mesenchymal stem cells, alginate hydrogel, liver cirrhosis, liver regeneration, liver fibrosis, cell retention, future liver remnant, liver cancer surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.